Liposome-Encapsulated Prednisolone Phosphate Inhibits Growth of Established Tumors in Mice
Tài liệu tham khảo
Almawi, 2002, Molecular mechanisms of glucocorticoid antiproliferative effects antagonism of transcription factor activity by glucocorticoid receptor, J Leukoc Biol, 71, 9, 10.1189/jlb.71.1.9
Folkman, 1983, Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone, Science, 221, 719, 10.1126/science.6192498
Pucci, 1988, Modulation of growth of melanoma, IntJ Dermatol, 27, 167, 10.1111/j.1365-4362.1988.tb04922.x
Metselaar, 2003, Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes, Arthritis Rheum, 48, 2059, 10.1002/art.11140
Schraa, 2002, Targeting of RGD-modified proteins to tumor vasculature a pharmacokinetic and cellular distribution study, Int J Cancer, 102, 469, 10.1002/ijc.10727
Harrington, 2001, Liposomal cancer chemotherapy current clinical applications and future prospects, Expert Opin Invest Drugs, 10, 1045, 10.1517/13543784.10.6.1045
Gabizon, 1997, Polyethylene glycol-coated (pegylated) liposomal doxorubicin, Rationale for use in solid tumours. Drugs, 54, 15
Crowley, 1998, Inhibition of growth of B16F10 melanoma by glucocorticoids does not result directly from receptor-mediated inhibition of tumour cells, Oncology, 45, 331, 10.1159/000226634
Ingber, 1986, A possible mechanism for inhibition of angiogenesis by angiostatic steroids induction of capillary basement membrane dissolution, Endocrinology, 119, 1768, 10.1210/endo-119-4-1768
Blei, 1993, Mechanism of action of angiostatic steroids suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis, J Cell Physiol, 155, 568, 10.1002/jcp.1041550315
Nauck, 1998, Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells, Eur J Pharmacol, 341, 309, 10.1016/S0014-2999(97)01464-7
Bingle, 2002, The role of tumour-associated macrophages in tumour progression implications for new anticancer therapies, J Pathol, 196, 254, 10.1002/path.1027
O'Byrne, 2001, Chronic immune activation and inflammation as the cause of malignancy, Br J Cancer, 85, 473, 10.1054/bjoc.2001.1943
Bingle, 2002, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, J Pathol, 196, 254, 10.1002/path.1027
Bergers, 1999, Effects of angiogenesis inhibitors on multistage carcinogenesis in mice, Science, 284, 808, 10.1126/science.284.5415.808
